Drug discontinued-text Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Lamisil Tablets 250mg. The Food and Drug Administration (FDA) posted a ...
The US Food and Drug Administration (FDA) has approved a new formulation of the triazole antifungal posaconazole (Noxafil, Merck), the manufacturer announced today. The agency approved posaconazole ...